Skip to main content
. 2024 Sep 20;55(5):1264–1271. [Article in Chinese] doi: 10.12182/20240960602

表 3. Resistance and susceptibility rates of 1152 Escherichia coli isolates to antimicrobial agents in 2019 to 2023.

2019−2023年1152株大肠埃希菌对抗菌药物的耐药率和敏感率

Antimicrobial agents 2019 2020 2021 2022 2023 χ2/P
R/% S/% R/% S/% R/% S/% R/% S/% R/% S/%
 R: resistant; S: susceptible.
Amikacin 2.5 97.5 1.6 98.4 3.4 96.6 2.2 97.8 0.9 99.1 3.454/0.485
Gentamicin 34.5 63.5 42.9 56.6 32.9 66.7 29.8 69.8 34.7 65.3 15.144/0.056
Imipenem 2.5 97.5 2.2 97.8 3.4 96.6 2.2 97.8 1.4 98.6 1.951/0.745
Meropenem 2.5 97.5 2.2 97.8 3.4 96.6 2.2 97.3 1.4 98.6 5.466/0.707
Ertapenem 2.5 97.5 2.2 97.8 3.9 96.1 2.7 97.3 1.4 98.6 2.703/0.609
Cefazolin 55.5 44.5 57.1 42.9 54.5 45.5 61.6 38.4 79.1 20.9 30.984/0.000
Cefuroxime 55.0 40.0 57.5 38.7 51.2 43.4 52.0 42.7 60.7 36.9 7.137/0.522
Ceftazidime 28.5 69.0 22.1 76.8 22.7 76.3 21.8 77.3 27.6 69.7 9.133/0.331
Cefotaxime 51.0 47.6 55.2 43.6 51.2 48.8 49.3 49.8 57.7 41.8 6.991/0.538
Cefepime 27.0 71.5 26.8 72.0 26.5 72.5 28.0 70.1 33.6 63.7 15.736/0.046
Piperacillin 79.0 18.0 82.3 17.7 83.4 16.1 79.9 19.2 84.4 15.1 13.154/0.107
Ampicillin 82.5 17.0 83.5 14.8 84.5 13.5 82.2 17.8 84.9 14.2 7.478/0.486
Cefoperazone-Sulbactam 5.6 88.3 4.4 86.8 6.2 80.7 4.8 80.1 6.9 67.4 35.933/0.000
Piperacillin-Tazobactam 17.7 81.8 11.2 86.6 18.4 79.6 10.8 86.5 12.5 84.0 13.108/0.108
Ampicillin-Sulbactam 57.3 42.7 47.8 52.2 48.8 51.2 42.0 57.1 45.9 51.4 25.436/0.001
Ciprofloxacin 61.5 24.5 65.4 29.1 65.2 29.5 60.4 32.4 69.2 28.0 25.100/0.001
Levofloxacin 56.5 17.0 64.1 16.6 58.0 30.0 54.7 36.9 63.0 32.9 76.304/0.000
Trimethoprim-Sulfamethoxazole 48.7 51.3 58.8 41.2 57.0 43.0 47.3 52.7 53.2 46.8 8.119/0.087
Nitrofurantoin 3.2 89.8 0 91.9 0 91.7 1.1 97.7 0.8 96.1 14.505/0.070